142 related articles for article (PubMed ID: 2471560)
1. Induction of proliferation and blast transformation by interferon in human malignant and non-malignant lymph node B cells.
Ostlund L; Biberfeld P; Robèrt KH; Christensson B; Einhorn S
Blood; 1989 Jun; 73(8):2171-81. PubMed ID: 2471560
[TBL] [Abstract][Full Text] [Related]
2. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
3. Soluble factor(s) released by Concanavalin A activated lymph node lymphocytes induce proliferation and maturation of chronic lymphocytic leukaemia (CLL) B lymphocytes.
Matera L; Massaia M; Pegoraro L
J Clin Lab Immunol; 1984 Feb; 13(2):85-8. PubMed ID: 6427468
[TBL] [Abstract][Full Text] [Related]
4. Induction of 2',5'-oligoadenylate synthetase and blast transformation in primary chronic lymphocytic leukemia cells following exposure to interferon in vitro.
Ostlund L; Einhorn S; Robèrt KH
Cancer Res; 1986 Apr; 46(4 Pt 2):2160-3. PubMed ID: 2418964
[TBL] [Abstract][Full Text] [Related]
5. Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro.
Ostlund L; Einhorn S; Robèrt KH; Juliusson G; Biberfeld P
Blood; 1986 Jan; 67(1):152-9. PubMed ID: 2416366
[TBL] [Abstract][Full Text] [Related]
6. T and B cell populations in blood and lymph node in lymphoproliferative disease.
Cooper DA; Petts V; Luckhurst E; Biggs JC; Penny R
Br J Cancer; 1975 May; 31(5):550-8. PubMed ID: 1080424
[TBL] [Abstract][Full Text] [Related]
7. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
[TBL] [Abstract][Full Text] [Related]
8. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia.
Mayer R; Logtenberg T; Strauchen J; Dimitriu-Bona A; Mayer L; Mechanic S; Chiorazzi N; Borche L; Dighiero G; Mannheimer-Lory A
Blood; 1990 Apr; 75(7):1518-24. PubMed ID: 1690580
[TBL] [Abstract][Full Text] [Related]
9. Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathologic study.
McCurley TL; Collins RD; Ball E; Collins RD
Hum Pathol; 1990 May; 21(5):482-92. PubMed ID: 2110929
[TBL] [Abstract][Full Text] [Related]
10. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
11. Interferon induces proliferation in leukemic and normal B-cell subsets.
Robért KH; Einhorn S; Ostlund L; Juliusson G; Biberfeld P
Hematol Oncol; 1986; 4(2):113-20. PubMed ID: 2427428
[TBL] [Abstract][Full Text] [Related]
12. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
Wessel H
Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
[TBL] [Abstract][Full Text] [Related]
13. Report of an unusual small lymphocytic B-cell lymphoma selectively involving the B-zone of lymph node.
Carbone A; Pinto A; Gloghini A; De Re V; Alosi M; Zagonel V; Tirelli U; Attadia V; Boiocchi M; Volpe R
Cancer; 1990 Jul; 66(2):302-12. PubMed ID: 2196112
[TBL] [Abstract][Full Text] [Related]
14. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
Lewis RE; Johnson WW; Cruse JM
Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
[No Abstract] [Full Text] [Related]
15. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
16. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in lymphoproliferative diseases.
Kelényi G
Zentralbl Allg Pathol; 1990; 136(1-2):33-42. PubMed ID: 2183531
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
Liendo C; Danieu L; Al-Katib A; Koziner B
Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
[TBL] [Abstract][Full Text] [Related]
19. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
[TBL] [Abstract][Full Text] [Related]
20. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
